Press Releases

Press Releases

Oct 20, 2020
GAITHERSBURG, Md. , Oct. 20, 2020 (GLOBE NEWSWIRE) -- Novavax , Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn , M.D, President of Research & Development, will present on NVX-CoV2373,...
Oct 05, 2020
GAITHERSBURG, Md. , Oct. 05, 2020 (GLOBE NEWSWIRE) -- Novavax Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in four upcoming investor and industry conferences....
Sep 10, 2020
GAITHERSBURG, Md. , Sept. 10, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will participate in five upcoming investor conferences....
Sep 08, 2020
-- Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines -- NEW YORK --(BUSINESS WIRE)--Sep. 8, 2020-- The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX),...
Displaying 1 - 10 of 192